Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China

International Journal of STD and AIDS

Volumn 26, Issue 3, 2015, Pages 156-164

  Mijiti, Peierdun ^a   Yuexin, Zhang ^a   Min, Liu ^b   Wubuli, Maimaitili ^a   Kejun, Pan ^a   Upur, Halmurat ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

AIDS; anaemia; antiretroviral therapy; China; haemoglobin; HIV; predictors; prevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE; TUBERCULOSTATIC AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CHINA; DISEASE SEVERITY; ETHNICITY; FEMALE; FOLLOW UP; GENDER; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; THRUSH; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMPLICATION; HIV INFECTIONS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANEMIA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; CHINA; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84922742566     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462414531935     Document Type: Article

References (52)

1. De Santis GC,Brunetta DM,Vilar FC, et al.Hematological abnormalities in HIV-infected patients.Int J Infect Dis. 2011;15:e808-e811
2. Sullivan PS,Hanson DL,Chu SY, et al.Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project.Blood. 1998;91:301-308
3. Fangman JJ,Scadden DT.Anemia in HIV-infected adults: epidemiology, pathogenesis, and clinical management.Curr Hematol Rep. 2005;4:95-102
4. Claster S.Biology of anemia, differential diagnosis, and treatment options in human immunodeficiency virus infection.J Infect Dis. 2002;185:S105-S109
5. Bolge SC,Mody S,Ambegaonkar BM, et al.The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy.Curr Med Res Opin. 2007;23:803-810
6. Mocroft A,Kirk O,Barton SE, et al.Anemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group.AIDS. 1999;13:943-950
7. Mocroft A,Lifson AR,Touloumi G, et al.Haemoglobin and anemia in the SMART study.Antivir Ther. 2011;16:329-337
8. Moore RD,Keruly JC,Chaisson RE.Anemia and survival in HIV infection.J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:29-33
9. O'Brien ME,Kupka R,Msamanga GI, et al.Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania.J Acquir Immune Defic Syndr. 2005;40:219-225
10. Buskin SE,Sullivan PS.Anemia and its treatment and outcomes in persons infected with human immunodeficiency virus.Transfusion. 2004;44:826-832
11. Page ID,McKew SJ,Kudzala AG, et al.Screening HIV-infected adults in Malawi for anemia: impact on eligibility for antiretroviral therapy.Int J STD AIDS. 2013;24:449-453
12. Berhane K,Karim R,Cohen MH, et al.Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.J Acquir Immune Defic Syndr. 2004;37:1245-1252
13. Moore RD,Forney D.Anemia in HIV-infected patients receiving highly active antiretroviral therapy.J Acquir Immune Defic Syndr. 2002;29:54-57
14. Semba RD,Shah N,Vlahov D.Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy.J Acquir Immune Defic Syndr. 2001;26:315-319
15. Bunupuradah T,Kariminia A,Chan KC, et al.Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy.Int J Infect Dis. 2013;17:e806-e810
16. Zhao DC,Wen Y,Ma Y, et al.Expansion of China's free antiretroviral treatment program.Chin Med J (Engl). 2012;125:3514-3521
17. Zhu H,Napravnik S,Eron JJ, et al.Decreasing excess mortality of HIV-infected patients initiating antiretroviral therapy: comparison with mortality in general population in China, 2003–2009.J Acquir Immune Defic Syndr. 2013;63:e150-e157
18. Shen Y,Wang Z,Lu H, et al.Prevalence of anemia among adults with newly diagnosed HIV/AIDS in China.PLoS One. 2013;8:e73807
19. Zhang F,Dou Z,Ma Y, et al.Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study.Lancet Infect Dis. 2011;11:516-524
20. Zhang F,Dou Z,Ma Y, et al.Five-year outcomes of the China National Free Antiretroviral Treatment Program.Ann Intern Med. 2009;151:241-251
21. Ma Y,Zhang F,Zhao Y, et al.Cohort profile: the Chinese national free antiretroviral treatment cohort.Int J Epidemiol. 2010;39:973-979
22. Dou Z,Chen RY,Xu J, et al.Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09.Int J Epidemiol. 2010;39:ii56-ii64
23. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization; 2011:
24. Shi Z,Zhang C,Zhou M, et al.Exposure to the Chinese famine in early life and the risk of anemia in adulthood.BMC Public Health. 2013;13:904
25. Zhang L,Wang F,Wang L, et al.Prevalence of chronic kidney disease in China: a cross-sectional survey.Lancet. 2012;379:815-822
26. Piao JH,Lai JQ,Yin SA, et al.Study on anemia status of Chinese population (In Chinese).Acta Nutrimenta Sinica. 2005;27:268-271
27. Volberding PA,Levine AM,Dieterich D, et al.Anemia in HIV infection: clinical impact and evidence-based management strategies.Clin Infect Dis. 2004;38:1454-1463
28. Meidani M,Rezaei F,Maracy MR, et al.Prevalence, severity, and related factors of anemia in HIV/AIDS patients.J Res Med Sci. 2012;17:138-142
29. Subbaraman R,Devaleenal B,Selvamuthu P, et al.Factors associated with anemia in HIV-infected individuals in southern India.Int J STD AIDS. 2009;7:489-492
30. Ferede G,Wondimeneh Y.Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia.BMC Hematol. 2013;13:8
31. Gedefaw L,Yemane T,Sahlemariam Z, et al.Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.PLoS One. 2013;8:e72202
32. Dabrowska MM,Mikula T,Wiercinska-Drapalo A.The anemia prevalence and the association between complete blood count analysis and renal function parameters in HIV-1-infected patients.Curr HIV Res. 2012;10:247-251
33. De Santis GC,Brunetta DM,Vilar FC, et al.Hematological abnormalities in HIV-infected patients.Int J Infect Dis. 2011;15:e808-e811
34. Lundgren JD,Mocroft A.Anemia and survival in human immunodeficiency virus.Clin Infect Dis. 2003;37 (Suppl 4): S297-S303
35. Srasuebkul P,Lim PL,Lee MP, et al.Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database.Clin Infect Dis. 2009;48:940-950
36. Makubi A, Okuma J, Spiegelman D, et al. Burden and Determinants of Severe Anemia among HIV-Infected Adults: Results from a Large Urban HIV Program in Tanzania, East Africa. J Int Assoc Provid AIDS Care 2013. doi: 10.1177/2325957413488195.
37. Takuva S,Maskew M,Brennan AT, et al.Anemia among HIV-infected patients initiating antiretroviral therapy in South Africa: improvement in hemoglobin regardless of degree of immunosuppression and the initiating ART regimen.J Trop Med. 2013;2013:162950
38. O'Connell C,Levine AM.Managing anemia in HIV-positive women.Womens Health (Lond Engl). 2006;2:159-165
39. Li HJ,Liu DX,Li L, et al.Hemoglobinopathies in Xinjiang.Hemoglobin. 1986;10:435-449
40. Kawai K,Villamor E,Mugusi FM, et al.Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania.Int J Tuberc Lung Dis. 2011;15:1380-1389
41. Egusa H,Soysa NS,Ellepola AN, et al.Oral candidosis in HIV-infected patients.Curr HIV Res. 2008;6:485-499
42. Lu SY,Wu HC.Initial diagnosis of anemia from sore mouth and improved classification of anemia by MCV and RDW in 30 patients.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:679-685
43. Weiss G,Goodnough LT.Anemia of chronic disease.N Engl J Med. 2005;352:1011-1023
44. Jelkmann W.Proinflammatory cytokines lowering erythropoietin production.J Interferon Cytokine Res. 1998;18:555-559
45. Schwenk A,Macallan DC.Tuberculosis, malnutrition and wasting.Curr Opin Clin Nutr Metab Care. 2000;3:285-291
46. Ramadan IT,Abdul-Ghaffar NU.Malabsorption syndrome complicating tuberculous peritonitis.Int J Tuberc Lung Dis. 1997;1:85-86
47. Verdalles U,Abad S,Vega A, et al.Factors related to the absence of anemia in hemodialysis patients.Blood Purif. 2011;32:69-74
48. Alsaran KA,Sabry AA,Alghareeb AH, et al.Effect of hepatitis C virus on hemoglobin and hematocrit levels in Saudi hemodialysis patients.Ren Fail. 2009;31:349-354
49. Wan Q, He Y, Zhang W, et al. Prevalence and related factors of the absence of anemia among Chinese chronic hemodialysis patients: a multicenter cross-sectional study. Int Urol Nephrol 2013. doi:10.1007/s1125501305811.
50. Khurana A,Nickel AE,Narayanan M, et al.Effect of hepatitis C infection on anemia in hemodialysis patients.Hemodial Int. 2008;12:94-99
51. Jang ES,Jeong SH,Hwang SH, et al.Effects of coffee, smoking, and alcohol on liver function tests: a comprehensive cross-sectional study.BMC Gastroenterol. 2012;12:145
52. Lee SW,Kang YA,Yoon YS, et al.The prevalence and evolution of anemia associated with tuberculosis.J Korean Med Sci. 2006;21:1028-1032